Matthew W Semler1, Annis M Marney2, Todd W Rice3, Hui Nian4, Chang Yu4, Arthur P Wheeler3, Nancy J Brown5. 1. Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN. Electronic address: matthew.w.semler@vanderbilt.edu. 2. Frist Clinic, Endocrinology, Nashville, TN. 3. Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN. 4. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN. 5. Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Abstract
BACKGROUND:Conservative fluid management increases ventilator-free days without influencing overall mortality in acute respiratory distress syndrome. Plasma concentrations of B-type natriuretic peptide (a marker of ventricular filling) or aldosterone (a marker of effective circulating volume) may identify patients for whom fluid management impacts survival. METHODS: This was a retrospective analysis of the Fluid and Catheter Treatment Trial (FACTT), a randomized trial comparing conservative with liberal fluid management in acute respiratory distress syndrome. Using plasma collected at study enrollment, we measured B-type natriuretic peptide and aldosterone by immunoassay. Multivariable analyses examined the interaction between B-type natriuretic peptide or aldosterone concentration and fluid strategy with regard to 60-day in-hospital mortality. RESULTS: Among 625 patients with adequate plasma, median B-type natriuretic peptide concentration was 825 pg/mL (interquartile range, 144-1,574 pg/mL), and median aldosterone was 2.49 ng/dL (interquartile range, 1.1-4.3 ng/dL). B-type natriuretic peptide did not predict overall mortality, correlate with fluid balance, or modify the effect of conservative vs liberal fluid management on outcomes. In contrast, among patients with lower aldosterone concentrations, conservative fluid management increased ventilator-free days (17.1 ± 9.8 vs 12.5 ± 10.3, P < .001) and decreased mortality (19% vs 30%, P = .03) (P value for interaction = .01). CONCLUSIONS: In acute respiratory distress syndrome, B-type natriuretic peptide does not modify the effect of fluid management on outcomes. Lower initial aldosterone appears to identify patients for whom conservative fluid management may improve mortality.
RCT Entities:
BACKGROUND: Conservative fluid management increases ventilator-free days without influencing overall mortality in acute respiratory distress syndrome. Plasma concentrations of B-type natriuretic peptide (a marker of ventricular filling) or aldosterone (a marker of effective circulating volume) may identify patients for whom fluid management impacts survival. METHODS: This was a retrospective analysis of the Fluid and Catheter Treatment Trial (FACTT), a randomized trial comparing conservative with liberal fluid management in acute respiratory distress syndrome. Using plasma collected at study enrollment, we measured B-type natriuretic peptide and aldosterone by immunoassay. Multivariable analyses examined the interaction between B-type natriuretic peptide or aldosterone concentration and fluid strategy with regard to 60-day in-hospital mortality. RESULTS: Among 625 patients with adequate plasma, median B-type natriuretic peptide concentration was 825 pg/mL (interquartile range, 144-1,574 pg/mL), and median aldosterone was 2.49 ng/dL (interquartile range, 1.1-4.3 ng/dL). B-type natriuretic peptide did not predict overall mortality, correlate with fluid balance, or modify the effect of conservative vs liberal fluid management on outcomes. In contrast, among patients with lower aldosterone concentrations, conservative fluid management increased ventilator-free days (17.1 ± 9.8 vs 12.5 ± 10.3, P < .001) and decreased mortality (19% vs 30%, P = .03) (P value for interaction = .01). CONCLUSIONS: In acute respiratory distress syndrome, B-type natriuretic peptide does not modify the effect of fluid management on outcomes. Lower initial aldosterone appears to identify patients for whom conservative fluid management may improve mortality.
Authors: Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin Journal: N Engl J Med Date: 2006-05-21 Impact factor: 91.245
Authors: G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg Journal: Am J Respir Crit Care Med Date: 1994-03 Impact factor: 21.405
Authors: Nor'azim Mohd Yunos; Rinaldo Bellomo; Colin Hegarty; David Story; Lisa Ho; Michael Bailey Journal: JAMA Date: 2012-10-17 Impact factor: 56.272
Authors: Rochus Witthaut; Christian Busch; Peter Fraunberger; Autar Walli; Dietrich Seidel; Günter Pilz; Ralph Stuttmann; Norbert Speichermann; Ljifane Verner; Karl Werdan Journal: Intensive Care Med Date: 2003-08-12 Impact factor: 17.440
Authors: Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan Journal: Circulation Date: 2004-02-10 Impact factor: 29.690
Authors: Roderick H Tung; Christine Garcia; Alexander M Morss; Richard M Pino; Michael A Fifer; B Taylor Thompson; Kent Lewandrowski; Elizabeth Lee-Lewandrowski; James L Januzzi Journal: Crit Care Med Date: 2004-08 Impact factor: 7.598
Authors: Matt S Zinter; Aaron C Spicer; Kathleen D Liu; Benjamin E Orwoll; Mustafa F Alkhouli; Paul R Brakeman; Carolyn S Calfee; Michael A Matthay; Anil Sapru Journal: Pediatr Crit Care Med Date: 2019-04 Impact factor: 3.624
Authors: Thomas S Metkus; Eliseo Guallar; Lori Sokoll; David A Morrow; Gordon Tomaselli; Roy Brower; Bo Soo Kim; Steven Schulman; Frederick K Korley Journal: J Crit Care Date: 2018-08-16 Impact factor: 3.425
Authors: Matthew W Semler; Jonathan P Wanderer; Jesse M Ehrenfeld; Joanna L Stollings; Wesley H Self; Edward D Siew; Li Wang; Daniel W Byrne; Andrew D Shaw; Gordon R Bernard; Todd W Rice Journal: Am J Respir Crit Care Med Date: 2017-05-15 Impact factor: 21.405
Authors: Nareg H Roubinian; Mark R Looney; Sheila Keating; Daryl J Kor; Clifford A Lowell; Ognjen Gajic; Rolf Hubmayr; Michael Gropper; Monique Koenigsberg; Gregory A Wilson; Michael A Matthay; Pearl Toy; Edward L Murphy Journal: Transfusion Date: 2017-05-03 Impact factor: 3.157